The short version
12 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.
Market view
dexmedetomidine hydrochloride · Injection, Solution
38 marketed package NDCs · 12 active manufacturers
Most dispensed: 4 ug/mL · Injection, Solution · #10 bottles/tray / 100 ml in 1 bottle · 4 ug/mL · Injection, Solution · #10 vials/carton / 20 ml in 1 vial · 4 ug/mL · Injection, Solution · #20 bottles/tray / 50 ml in 1 bottle
What changed in the last 90 days
Every detected change for dexmedetomidine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Dexmedetomidine HydrochlorideAug 12, 2026Mfr exitedSlayback Pharma LLC · dexmedetomidine hydrochloride
- Dexmedetomidine HydrochlorideJul 22, 2026New shortageby this manufacturerSomerset Therapeutics, LLC's Dexmedetomidine Hydrochloride (Injection, 100 ug/1 mL) is newly in shortage31 companies market dexmedetomidine hydrochloride · 16 have products in shortage
- Dexmedetomidine HydrochlorideJul 22, 2026New shortageby this manufacturerSomerset Therapeutics, LLC's Dexmedetomidine Hydrochloride (Injection, 100 ug/1 mL) is newly in shortage31 companies market dexmedetomidine hydrochloride · 16 have products in shortage
Same drug class
Other molecules FDA puts in Central alpha-2 Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- dexmedetomidine hcl· in shortage
- dexmedetomidine hydrochloride in 0.9% sodium chloride· in shortage
- dexmedetomidine· in shortage
- clonidine hci· 1 maker
- clonidine hydrochloride oral· 1 maker
- dexmedetomidine hydrochloride in sodium chloride· 1 maker
- tizandine· 1 maker
- clonidine transdermal system· 2 makers
- guanfacine er· 2 makers
- tizanidine hcl· 2 makers
- gaunfacine· 3 makers
- methyldopa· 4 makers
Common questions
- Is Dexmedetomidine hydrochloride in shortage right now?
- Yes. FDA currently lists Dexmedetomidine hydrochloride in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.
- Who makes Dexmedetomidine hydrochloride?
- 31 companies have marketed Dexmedetomidine hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)Apr 10, 2020
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)Apr 10, 2020
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)Apr 10, 2020
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)Apr 10, 2020
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)Apr 10, 2020
- In shortage now — Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)Apr 10, 2020
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.